AMEX:SENS   Senseonics Holdings, Inc
Breaking out of this triangle, solid move so far this week. Anticipation of FDA approval of 180 day wearable glucose monitor as the driver and potential catalyst for more...also risky for that reason


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.